Analysis of Crosstalk Between Pathogens and Immune System in Human Airway Mucus via Machine Learning‐Enhanced DIA Mass Spectrometry

We demonstrate excellent depth of proteome coverage and experimental repeatability for low-abundance pathogen proteomes in human airway secretions via data-independent acquisition liquid chromatography tandem mass spectrometry leveraging machine learning for spectral analysis. The host's sputum proteome was also profiled, allowing inferences of immune defense mechanisms against pathogens. This proof-of-principle study shows the opportunity to gain insights into respiratory disease burdens and bacterial virulence by directly analyzing clinical specimens and the potential for biomarker discovery and pharmacodynamic response monitoring in interventional studies related to respiratory tract infections.

Authors

Institutions

Publication Details

Journal
PROTEOMICS - CLINICAL APPLICATIONS
Published
2025-10-17
DOI
https://doi.org/10.1002/prca.70026
Citations
1
Primary Topic
Microbial infections and disease research
Type
article
Field-Weighted Citation Impact
1.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of Crosstalk Between Pathogens and Immune System in Human Airway Mucus via Machine Learning‐Enhanced DIA Mass Spectrometry

Jeroen Aerssens, Vinod Krishna, Rembert Pieper, Thomas N. Gaitanos
1 citations
PROTEOMICS - CLINICAL APPLICATIONS
Microbial infections and disease research
1.18
article

Analysis of Crosstalk Between Pathogens and Immune System in Human Airway Mucus via Machine Learning‐Enhanced DIA Mass Spectrometry

Jeroen Aerssens, Vinod Krishna, Rembert Pieper, Thomas N. Gaitanos
article en
1 citations

Abstract

We demonstrate excellent depth of proteome coverage and experimental repeatability for low-abundance pathogen proteomes in human airway secretions via data-independent acquisition liquid chromatography tandem mass spectrometry leveraging machine learning for spectral analysis. The host's sputum proteome was also profiled, allowing inferences of immune defense mechanisms against pathogens. This proof-of-principle study shows the opportunity to gain insights into respiratory disease burdens and bacterial virulence by directly analyzing clinical specimens and the potential for biomarker discovery and pharmacodynamic response monitoring in interventional studies related to respiratory tract infections.

PROTEOMICS - CLINICAL APPLICATIONSVol. 19(6)
Johnson & Johnson (United States) (US), Janssen (Belgium) (BE), Evotec (Germany) (DE), Johnson & Johnson (Brazil) (BR)
Openalex Percentile: Top 17%
Microbial infections and disease research
1.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.